Aug 15 (Reuters) - HLS Therapeutics Inc HLS.V :
* HLS THERAPEUTICS ANNOUNCES Q2 2018 FINANCIAL RESULTS
* Q2 LOSS PER SHARE $0.02
* SETS QUARTERLY DIVIDEND OF C$0.05PER SHARE
* QTRLY TOTAL REVENUE $16.3 MILLION VERSUS $18.9 MILLION
* HLS THERAPEUTICS - ENTERED NEW SENIOR SECURED TERM LOAN WITH SYNDICATE OF BANK LENDERS
* PRINCIPAL AMOUNT OF NEW SENIOR SECURED TERM LOAN IS $100.0 MILLION
* IN ADDITION, THERE IS A $25.0 MILLION REVOLVING FACILITY THAT IS UNDRAWN ON CLOSING
* HLS THERAPEUTICS - MAY ALSO REQUEST TO BE PROVIDED WITH INCREMENTAL LOANS, FOR MAXIMUM ADDITIONAL LOAN OF $100 MILLION
* MATURITY DATE OF LOAN IS AUGUST 15, 2023
* PROCEEDS FROM NEW SENIOR SECURED TERM LOAN,AVAILABLE CASH BALANCES USED TO REPAY CO'S EXISTING SENIOR SECURED TERM LOAN IN FULL